tiprankstipranks
Trending News
More News >

RTW INVESTMENTS, LP Insider Profile

4 Followers
RTW INVESTMENTS, LP, Ten Percent Owner at Milestone Pharmaceuticals, holds 190.78K shares in Allurion Technologies (Ticker: ALUR), holds 5.18M shares in CARGO Therapeutics, Inc. (Ticker: CRGX), holds 18.16M shares in Rocket Pharmaceuticals (Ticker: RCKT). Most recently, RTW INVESTMENTS, LP Bought ― shares of Allurion Technologies on Apr 17, 2025 for an estimated value of 5.00M.
tipranks
RTW INVESTMENTS, LP

RTW INVESTMENTS, LP
Milestone Pharmaceuticals (MIST)
Ten Percent Owner

Ranked #14,170 out of 101,378 Corporate Insiders

Profitable Transactions

33%
15 out of 45 Profitable Transactions

Average Return

+5.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$414M
30.85%
27.74%
23.93%
6.58%
10.90% Others
A breakdown of RTW INVESTMENTS, LP's holdings

Insider Roles

Avidity Biosciences
(RNA)
Ten Percent Owner
Rocket Pharmaceuticals
(RCKT)
Director, See remarks, Ten Percent Owner
Tarsus Pharmaceuticals
(TARS)
Ten Percent Owner
Stoke Therapeutics
(STOK)
Ten Percent Owner
+7 other positions
Roles that RTW INVESTMENTS, LP holds in companies

Most Profitable Insider Trade

Stock:
DermTech
(DMTKQ)
Rating:Informative Buy
Date:Apr 01, 2020 - Apr 01, 2021
Return:+396.40%
The most profitable trade made by RTW INVESTMENTS, LP

RTW INVESTMENTS, LP's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Milestone Pharmaceuticals
Mar 24, 2023
Ten Percent Owner
Uninformative Sell
$2.89M
TELA Bio
Dec 18, 2019
Ten Percent Owner
Informative Sell
407.52K
$1.09M
DermTech
Nov 08, 2022
Ten Percent Owner
Informative Sell
176.00K
$60.37K
Avidity Biosciences
Aug 06, 2021
Ten Percent Owner
Informative Buy
14.40M
$127.83M
Athira Pharma
Sep 22, 2020
Ten Percent Owner
Uninformative Buy
$637.87K
LABP
Landos Biopharma
Sep 27, 2022
Informative Sell
207.00K
$91.16M
RXDX
Prometheus Biosciences
Mar 16, 2021
Uninformative Buy
$652.55M
Tarsus Pharmaceuticals
May 07, 2021
Ten Percent Owner
Informative Sell
13.49M
$99.17M
RCOR
Renovacor
Apr 05, 2023
Uninformative Sell
$0.00
Orchestra BioMed Holdings
May 05, 2023
Ten Percent Owner
Uninformative Buy
$16.02M
CARGO Therapeutics, Inc.
Jan 16, 2024
Ten Percent Owner
Uninformative Sell
$24.02M
Allurion Technologies
Apr 17, 2025
Director, Ten Percent Owner
Informative Buy
5.00M
$446.43K
Rocket Pharmaceuticals
Aug 30, 2023
Director, See remarks, Ten Percent Owner
Uninformative Buy
18.96M
$114.94M
Stoke Therapeutics
Nov 12, 2019
Ten Percent Owner
Informative Sell
471.49K
$27.26M
List of latest transactions for each holding click on a transaction to see RTW INVESTMENTS, LP's performance on stock

RTW INVESTMENTS, LP insider profile FAQ

What is the percentage of profitable transactions made by RTW INVESTMENTS, LP?
The percentage of profitable transactions made by RTW INVESTMENTS, LP is 33%.
    What is the average return per transaction made by RTW INVESTMENTS, LP?
    The average return per transaction made by RTW INVESTMENTS, LP is 5.00%.
      What stocks does RTW INVESTMENTS, LP hold?
      RTW INVESTMENTS, LP holds: MIST, TELA, DMTKQ, RNA, ATHA, LABP, RXDX, TARS, RCOR, OBIO, CRGX, ALUR, RCKT, STOK stocks.
        What was RTW INVESTMENTS, LP’s latest transaction?
        RTW INVESTMENTS, LP latest transaction was an Informative Buy of $5.00M.
          What was RTW INVESTMENTS, LP's most profitable transaction?
          RTW INVESTMENTS, LP’s most profitable transaction was an Informative Buy of DMTKQ stock on April 1, 2020. The return on the trade was 396.40%.
            What is RTW INVESTMENTS, LP's role in Milestone Pharmaceuticals?
            RTW INVESTMENTS, LP's role in Milestone Pharmaceuticals is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.